Underlying mechanism of antimicrobial activity of chitosan microparticles and implications for the treatment of infectious diseases

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Jeon, Soo Jin ^a,b   Oh, Manhwan ^a,b   Yeo, Won Sik ^a,b   Galvão, Klibs N ^a,c   Jeong, Kwang Cheol ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c University of Florida College of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTIOFUR; CHITOSAN DERIVATIVE; CHITOSAN MICROPARTICLE; OUTER MEMBRANE PROTEIN A; SHIGA TOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL MEMBRANE; BACTERIAL SHEDDING; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERIOPHAGE; BACTERIUM MUTANT; BINDING ASSAY; DISEASE MODEL; DRUG BINDING; ESCHERICHIA COLI O157; GENE EXPRESSION; HEMOLYTIC UREMIC SYNDROME; IN VITRO STUDY; IN VIVO STUDY; INTRAUTERINE PATHOGENIC ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; METRITIS; NONHUMAN; OMPA GENE; PATHOGENIC ESCHERICHIA COLI; SALMONELLA ENTERICA; TREATMENT DURATION; VIBRIO CHOLERAE; VIRUS GENOME;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIOPHAGES; CATTLE; CHITOSAN; ESCHERICHIA COLI O157; LIPOPOLYSACCHARIDES; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; SHIGA TOXINS;

EID: 84899081922     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092723     Document Type: Article

References (43)

1. Rabea EI, Badawy MET, Stevens CV, Smagghe G, Steurbaut W (2003) Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 4: 1457-1465. (Pubitemid 37455555)
2. Chung YC, Wang HL, Chen YM, Li SL (2003) Effect of abiotic factors on the antibacterial activity of chitosan against waterborne pathogens. Bioresour Technol 88: 179-184.
3. Qi LF, Xu ZR, Jiang X, Hu CH, Zou XF (2004) Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res 339: 2693-2700. (Pubitemid 39425140)
4. Darmadji P, Izumimoto M (1994) Effect of chitosan in meat preservation. Meat Sci 38: 243-254.
5. Liu H, Du YM, Wang XH, Sun LP (2004) Chitosan kills bacteria through cell membrane damage. Int J Food Microbiol 95: 147-155. (Pubitemid 38993324)
6. Papineau AM, Hoover DG, Knorr D, Farkas DF (1991) Antimicrobial effect of water-Soluble chitosans with high hydrostatic pressure. Food Biotechnol 5: 45-57.
7. Shahidi F, Arachchi JKV, Jeon YJ (1999) Food applications of chitin and chitosans. Trends Food Sci Technol 10: 37-51. (Pubitemid 29306025)
8. US Food and Drug Administration (2012) Shrimp-derived chitosan GRAS notification. Available: www.accessdata.fda.gov/scripts/fcn/gras-notices/ GRN000443pdf. Accessed 2013 Dec 6.
9. Mahae N, Chalat C, Muhamud P (2011) Antioxidant and antimicrobial properties of chitosan-sugar complex. Int Food Res J 18: 1543-1551.
10. Sudarshan NR, Hoover DG, Knorr D (1992) Antibacterial action of chitosan. Food Biotechnol 6: 257-272. (Pubitemid 23588034)
11. Helander IM, Nurmiaho-Lassila EL, Ahvenainen R, Rhoades J, Roller S (2001) Chitosan disrupts the barrier properties of the outer membrane of Gram-negative bacteria. Int J Food Microbiol 71: 235-244. (Pubitemid 33123347)
12. Kong M, Chen XG, Xing K, Park HJ (2010) Antimicrobial properties of chitosan and mode of action: a state of the art review. Int J Food Microbiol 144: 51-63.
13. Jeong KC, Kang MY, Kang JH, Baumler DJ, Kaspar CW (2011) Reduction of Escherichia coli O157:H7 shedding in cattle by addition of chitosan microparticles to feed. Appl Environ Microbiol 77: 2611-2616.
14. van der Lubben IM, Verhoef JC, van Aelst AC, Borchard G, Junginger HE (2001) Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials 22: 687-694. (Pubitemid 32112293)
15. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97: 6640-6645. (Pubitemid 30412767)
16. Shu XZ, Zhu KJ (2001) Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation. J Microencapsul 18: 237-245. (Pubitemid 32177841)
17. Davydova VN, Bratskaya SY, Gorbach VI, Solov'eva TF, Kaca W, et al. (2008) Comparative study of electrokinetic potentials and binding affinity of lipopolysaccharides-chitosan complexes. Biophys Chem 136: 1-6.
18. Raetz CRH, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635-700. (Pubitemid 34800232)
19. Sheldon IM, Lewis GS, LeBlanc S, Gilbert RO (2006) Defining postpartum uterine disease in cattle. Theriogenology 65: 1516-1530.
20. Ozenc E, Seker E, Dogan N (2010) The effect of bacterial flora on uterine pH values, observed during the estrous cycle, gestation and in the cases of clinical metritis in cows. J Anim Vet Adv 9: 3000-3004.
21. Karmali MA (2004) Infection by shiga toxin-producing Escherichia coli - an overview. Mol Biotechnol 26: 117-122. (Pubitemid 39118023)
22. Rowe PC, Orrbine E, Lior H, Wells GA, Mclaine PN (1993) A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with hemolytic uremic syndrome. Epidemiol Infect 110: 1-7. (Pubitemid 23217322)
23. Grif K, Dierich MP, Karch H, Allerberger F (1998) Strain-specific differences in the amount of shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur J Clin Microbiol Infect Dis 17: 761-766. (Pubitemid 29219127)
24. Serna A, Boedeker EC (2008) Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol 24: 38-47.
25. Park D, Stanton E, Ciezki K, Parrell D, Bozile M, et al. (2013) Evolution of the Stx2-encoding prophage in persistent bovine Escherichia coli O157:H7 strains. Appl Environ Microbiol 79: 1563-1572.
26. Xing K, Chen XG, Liu CS, Cha DS, Park HJ (2009) Oleoyl-chitosan nanoparticles inhibits Escherichia coli and Staphylococcus aureus by damaging the cell membrane and putative binding to extracellular or intracellular targets. Int J Food Microbiol 132: 127-133.
27. Koebnik R, Locher KP, Van Gelder P (2000) Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Mol Microbiol 37: 239-253. (Pubitemid 30481009)
28. Pautsch A, Schulz GE (2000) High-resolution structure of the OmpA membrane domain. J Mol Biol 298: 273-282.
29. Killmann H, Benz R, Braun V (1993) Conversion of the Fhua transport protein into a diffusion channel through the outer membrane of Escherichia coli. Embo J 12: 3007-3016. (Pubitemid 23232731)
30. Klebba PE, Hofnung M, Charbit A (1994) A model of maltodextrin transport through the sugar-specific porin, LamB, based on deletion analysis. Embo J 13: 4670-4675. (Pubitemid 24310218)
31. Koebnik R (1999) Structural and functional roles of the surface-exposed loops of the beta-barrel membrane protein OmpA from Escherichia coli. J Bacteriol 181: 3688-3694.
32. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, et al. (2002) Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 347: 240-247. (Pubitemid 34787630)
33. Prasadarao NV (2002) Identification of Escherichia coli outer membrane protein A receptor on human brain microvascular endothelial cells. Infect Immun 70: 6513-6513.
34. Prasadarao NV, Srivastava PK, Rudrabhatla RS, Kim KS, Huang SH, et al. (2003) Cloning and expression of the Escherichia coli K1 outer membrane protein A receptor, a gp96 homologue. Infect Immun 71: 1680-1688. (Pubitemid 36368697)
35. Pascal TA, Abrol R, Mittal R, Wang Y, Prasadarao NV, et al. (2010) Experimental validation of the predicted binding site of Escherichia coli K1 outer membrane protein A to human brain microvascular endothelial Cells: identification of critical mutations that prevent E. coli meningitis. J Biol Chem 285: 37753-37761.
36. Kirn TJ, Jude BA, Taylor RK (2005) A colonization factor links Vibrio cholerae environmental survival and human infection. Nature 438: 863-866. (Pubitemid 41753069)
37. Lopez-Leon T, Carvalho ELS, Seijo B, Ortega-Vinuesa JL, Bastos-Gonzalez D (2005) Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. J Colloid Interface Sci 283: 344-351. (Pubitemid 40254961)
38. Sheldon IM, Cronin J, Goetze L, Donofrio G, Schuberth HJ (2009) Defining postpartum uterine disease and the mechanisms of infection and immunity in the female reproductive tract in cattle. Biol Reprod 81: 1025-1032.
39. Galvao KN, Greco LF, Vilela JM, Sa MF, Santos JEP (2009) Effect of intrauterine infusion of ceftiofur on uterine health and fertility in dairy cows. J Dairy Sci 92: 1532-1542.
40. McDougall S, Macaulay R, Compton C (2007) Association between endometritis diagnosis using a novel intravaginal device and reproductive performance in dairy cattle. Anim Reprod Sci 99: 9-23. (Pubitemid 46283250)
41. McLaughlin CL, Stanisiewski E, Lucas MJ, Cornell CP, Watkins J, et al. (2012) Evaluation of two doses of ceftiofur crystalline free acid sterile suspension for treatment of metritis in lactating dairy cows. J dairy sci 95: 4363-4371.
42. Dundas S, Todd WTA, Stewart AI, Murdoch PS, Chaudhuri AK, et al. (2001) The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis 33: 923-931. (Pubitemid 32907091)
43. Yoh M, Honda T (1997) The stimulating effect of fosfomycin, an antibiotic in common use in Japan, on the production/release of verotoxin-1 from enterohaemorrhagic Escherichia coli O157:H7 in vitro. Epidemiol Infect 119: 101-103. (Pubitemid 27379400)